Health-related quality of life with lisocabtagene maraleucel vs standard of care in relapsed or refractory LBCL
暂无分享,去创建一个
K. Izutsu | M. Lunning | J. Braverman | J. Abramson | S. Solomon | B. Glass | Shien Guo | M. Kamdar | J. Arnason | S. Ibrahimi | P. Johnston | F. Liu | A. Crotta | P. Mutsaers | S. Montheard | A. Previtali | L. Shi | Ling Shi